Results 251 to 260 of about 385,200 (307)

Co-Extracellular Vesicles Delivery System Enhances Immunochemotherapy for Glioblastoma. [PDF]

Research (Wash D C)
Niu W, Guan R, Sun L, Wang M, Wang X, Zhang B, Hao X, Wu Q, Cheng Z, Wei J, Wang Y, Zhang J, Fan JB.   +12 more
europepmc   +1 more source

Tumor‐Derived Exosomes Deliver Membrane‐Bound Fgl2 to Activate FcγRIIB‐Mediated Immunosuppression in Myeloid‐Derived Suppressor Cells

Advanced Science, EarlyView.
This study reveals that the Fgl2‐FcγRIIB signaling axis is a key mechanism by which MDSCs mediate tumor immune evasion. Tumor‐derived exosomes systemically activate MDSCs via this pathway, positioning this axis as a promising broad‐spectrum target for cancer immunotherapy.
Fenglin Lin, Dingqin Cai, Chunli Jian, Yaxian Qi, Linpeng Zheng, Qiao Yang, Longyao Zhang, Diangang Chen, Lingchen Li, Ping Cai, Lingyou Sun, Luping Zhang, Jianguo Sun   +12 more
wiley   +1 more source

Breaking barriers in peritoneal fibrosis: extracellular vesicles as promising diagnostic and therapeutic strategy. [PDF]

Ann Med
Zhong L, Zhang B, Li Y, Su B, Liao R.
europepmc   +1 more source

Extracellular Vesicles in Cancer: Mechanistic Insights and Clinical Applications. [PDF]

Cancers (Basel)
Alhumaydhi FA, Anwar S.
europepmc   +1 more source

Extracellular vesicles in viral disease management. [PDF]

Curr Res Microb Sci
Safeer F, Murali TS.
europepmc   +1 more source

The peritoneum in perspective: extracellular vesicles and the future of peritoneal dialysis. [PDF]

Ren Fail
Stepanova N.
europepmc   +1 more source

Endogenous Labelling of Extracellular Vesicles and Image Capture of Their Interactions With Acceptor Cells. [PDF]

Chembiochem
Booth E, Garre M, Wu D, O'Shea DF.
europepmc   +1 more source